Οι συχνοί εφιάλτες αυξάνουν τον κίνδυνο πρόωρου θανάτου [μελέτη]

Dear Colleagues,It is with great pleasure that we hereby welcome you to the upcoming 3rd Hematology & Oncology Course to be held by the Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine in collaboration with Mayo Clinic, USA. The goal of the Course is to present the latest data announced during the recent American Society of Clinical Oncology (ASCO) Annual Meeting and European Hematology Association (EHA) Annual Congress.Seventy-five esteemed professors from the National and Kapodistrian University of Athens and Mayo Clinic will be presenting the newest data pertaining to the diagnosis and treatment of solid tumors, hematologic neoplasms, as well as other hematologic diseases and disorders associated with blood coagulation.It should be noted that this is the very first event of this kind to be held in Greece, not to mention one that boasts the presence of distinguished scientists from one of the most important foundations in the world, namely Mayo Clinic. This Course will allow the Greek scientists who were not able to attend the meetings mentioned above to gain valuable insight into the latest developments in Oncology and Hematology.I wish you an enjoyable stay in Athens and a fruitful congress.Yours faithfully,Thanos DimopoulosProfessor and ChairmanPlasma Cell Dyscrasias UnitSection of Hematology and Medical OncologyDepartment of Clinical TherapeuticsSchool of MedicineNational and Kapodistrian University of AthensAlexandra Hospital